ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 72 filers reported holding ANTARES PHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $61,000 | +38.6% | 26,095 | 0.0% | 0.00% | – |
| Q3 2016 | $44,000 | +63.0% | 26,095 | 0.0% | 0.00% | – |
| Q2 2016 | $27,000 | -59.7% | 26,095 | -66.1% | 0.00% | – |
| Q1 2016 | $67,000 | -17.3% | 76,960 | +15.1% | 0.00% | – |
| Q4 2015 | $81,000 | -53.4% | 66,858 | -34.7% | 0.00% | – |
| Q3 2015 | $174,000 | -17.5% | 102,406 | +1.0% | 0.00% | – |
| Q2 2015 | $211,000 | -0.9% | 101,382 | +29.2% | 0.00% | – |
| Q1 2015 | $213,000 | +23.1% | 78,455 | +16.8% | 0.00% | – |
| Q4 2014 | $173,000 | +33.1% | 67,168 | -5.8% | 0.00% | – |
| Q3 2014 | $130,000 | -33.0% | 71,288 | -1.8% | 0.00% | – |
| Q2 2014 | $194,000 | -31.7% | 72,618 | -10.6% | 0.00% | – |
| Q1 2014 | $284,000 | -17.4% | 81,256 | +5.7% | 0.00% | – |
| Q4 2013 | $344,000 | +18.2% | 76,859 | +7.4% | 0.00% | – |
| Q3 2013 | $291,000 | +1.0% | 71,561 | +3.3% | 0.00% | – |
| Q2 2013 | $288,000 | – | 69,289 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,180,000 | 4.34% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,535,727 | $11,056,000 | 3.87% |
| Sargent Investment Group, LLC | 3,596,250 | $15,680,000 | 3.72% |
| Rubric Capital Management LP | 9,500,000 | $41,420,000 | 2.61% |
| PERKINS CAPITAL MANAGEMENT INC | 541,783 | $2,362,000 | 1.34% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $8,284,000 | 1.14% |
| Venator Capital Management Ltd. | 709,700 | $3,094,000 | 1.05% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $523,000 | 0.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $875,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,199,000 | 0.19% |